Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Rufinamide Given as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures
Epilepsy
(-)
009
Authors/Disclosures
Victor Biton, MD (AEP) Dr. Biton has nothing to disclose.
Alissa Butts No disclosure on file
Gregory Krauss, MD (Johns Hopkins University) Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Francesco Bibbiani, MD (Eisai) Dr. Bibbiani has nothing to disclose.
No disclosure on file
Allison D. Mann, MD (Pharmaceutical) Dr. Mann has received personal compensation for serving as an employee of Novartis Pharmaceutical.
Carlos Perdomo (Eisai Inc.) No disclosure on file
Milind Narurkar, PhD, PharmD No disclosure on file